|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.24 USD | -1.48% |
|
+2.05% | +0.38% |
| Market Cap | 1.68B 1.46B 1.36B 1.25B 2.36B 160B 2.39B 16.03B 6.29B 79.85B 6.31B 6.17B 268B | P/E 2026 * |
15.2x | P/E 2027 * | 13.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.84B 1.6B 1.49B 1.37B 2.58B 175B 2.62B 17.53B 6.88B 87.34B 6.9B 6.75B 293B | EV / Sales 2026 * |
1.64x | EV / Sales 2027 * | 1.3x |
| Free-Float |
86.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ANI Pharmaceuticals, Inc.
| 1 day | -1.48% | ||
| 1 week | +2.05% | ||
| 1 month | -7.89% | ||
| 3 months | -1.43% | ||
| 6 months | -0.95% | ||
| Current year | +0.38% |
| 1 week | 78.24 |  | 82 |
| 1 month | 76.42 | | 87.19 |
| Current year | 70.15 | | 87.76 |
| 1 year | 63.67 | | 99.5 |
| 3 years | 48.2 | | 99.5 |
| 5 years | 22.31 | | 99.5 |
| 10 years | 22.31 | | 99.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 48 | 2020-09-07 |
Stephen Carey
DFI | Director of Finance/CFO | 55 | 2016-05-05 |
Elizabeth Powell
CMP | Compliance Officer | - | 2022-02-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Haughey
CHM | Chairman | 62 | 2025-11-23 |
Antonio Pera
BRD | Director/Board Member | 68 | 2020-08-05 |
Jeanne A. Thoma
BRD | Director/Board Member | 66 | 2020-08-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/29/26 | Sell | Chief Financial Officer | -2,850 | 0.0125% | ||
| 7/18/26 | Tax | General Counsel | -2,466 | 0.0108% | ||
| 7/13/26 | Sell | General Counsel | -500 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | +2.05% | +23.95% | +54.98% | 1.68B | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +0.06% | -0.42% | +37.53% | +31.06% | 349B | |
| -0.69% | -0.30% | +13.76% | +13.84% | 264B | |
| -7.37% | -4.40% | -0.74% | -43.66% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.40% | +1.92% | +6.47% | -29.25% | 143B | |
| Average | -1.34% | -0.89% | +25.82% | +43.78% | 342.06B | |
| Weighted average by Cap. | -1.00% | -2.01% | +36.14% | +71.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.12B 975M 907M 833M 1.57B 107B 1.6B 10.7B 4.2B 53.3B 4.21B 4.12B 179B | 1.24B 1.08B 1B 922M 1.74B 119B 1.77B 11.84B 4.65B 59B 4.66B 4.56B 198B |
| Net income | 117M 102M 94.79M 87.03M 164M 11.18B 167M 1.12B 439M 5.57B 440M 430M 18.67B | 175M 152M 141M 130M 245M 16.69B 249M 1.67B 654M 8.31B 656M 642M 27.86B |
| Net Debt | 158M 137M 128M 117M 221M 15.04B 225M 1.5B 590M 7.49B 592M 579M 25.11B | -71.89M -62.49M -58.17M -53.41M -101M -6.86B -102M -686M -269M -3.42B -270M -264M -11.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$79.24 | -1.48% | 205,183 |
| 26-07-30 | US$80.43 | -1.65% | 192,636 |
| 26-07-29 | US$81.78 | +0.91% | 288,346 |
| 26-07-28 | US$81.04 | +3.41% | 219,650 |
| 26-07-27 | US$78.37 | +0.93% | 352,408 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIP Stock
Select your edition
All financial news and data tailored to specific country editions
